The impact of age on cost-effectiveness ratios and its control in decision making

Health Economics

Volumn 5, Issue 3, 1996, Pages 227-239

  Baltussen, Rob ^a   Leidl, Reiner ^a   Ament, André ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Age; Decision making; Economic evaluation

Indexed keywords

AGE; AGED; COST BENEFIT ANALYSIS; DECISION MAKING; DEMOGRAPHY; DEVELOPED COUNTRY; EQUIPMENT; HUMAN; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; DECISION MAKING; DEMOGRAPHY; DEVELOPED COUNTRIES; EFFECT MODIFIERS (EPIDEMIOLOGY); HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS;

EID: 0030135273     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199605)5:3<227::AID-HEC198>3.0.CO;2-Y     Document Type: Review

References (40)

1. Idenburg, P. and van Vondelen, A. European health care careful towards managed competition. Ziekenhuis 1993; 23: 597-617 (in Dutch).
2. Leidl, R. Effects of population ageing on health care, expenditure, and financing: some illustrations. In: Callahan, D., ter Meulen, R. H. J. and Topinkova, E. (eds). A world growing old: the coming health care challenges. Hasting Center Studies in Ethics. Washington, DC: Georgetown University Press 1995.
3. Alastair, M. G. and Bosanquet, N. Forecasting the impact of demographic change: the case of the British National Health Service. Health Policy, 1992; 20: 269-275.
4. Callahan, D. Old age and new policy. Journal of the American Medical Association, 1989; 261: 905-906.
5. Chelluri, L., Grenvik, A. and Silverman, M. Intensive care for critically ill elderly: mortality, costs and quality of life: review of the literature. Archives of Internal Medicine, 1995; 155: 1013-1022.
6. Rowe, J. W. Health care of the elderly. The New England Journal of Medicine, 1985; 312: 827-835.
7. Crosby, D. and Rees, G. Anaesthesia and surgery in the elderly. In: Pathy, M. S. J. (ed.) Principles and practice of geriatric medicine, pp. 1367-1883. Chichester: Wiley, 1985.
8. Evers, B. M., Townsend, C. M. and Thompson, J. C. Organ physiology of aging. Surgical Clinics of North America, 1994; 74: 23-39.
9. Millar, C. W., Survival and ambulation following hip fractures. Journal of Bone and Joint Surgery of America, 1978; 60: 930-934.
10. Nurmohamed, M. T., Buller, H. R. and ten Cate, J. W. Physiological changes due to age: implications for the prevention and treatment of thrombosis in older patients. Drugs and Ageing, 1994; 4: 207-220.
11. Lamy, P. P. Physiological changes due to age: pharmacodynamic changes of drug action and implications for therapy. Drugs and Ageing, 1991; 1: 385-404.
12. Morse, M. H., Jeans, W. D., Cole, S. E., Grier, D. and Ndlova, D. Complications in percutaneous transluminal angioplasty: relationships with patient age. British Journal of Radiology, 1991; 64: 5-9.
13. Lakatta, E. G., Cohen, J. D., Fleg, J. L., Frohlich, E. D. and Gradman, A. H. Hypertension in the elderly: age- and disease-related complications and therapeutic implications. Cardiovascular Drug Therapy, 1993; 7: 643-653.
14. Thulin, L. I. Age-related complications and optimal choice of artificial heart valves in elderly patients. Journal of Cardiovascular Surgery, 1991; 32: 497-502.
15. Sackett, D. L. and Torrance, G. W. The utility of different health states as perceived by the general public. Journal of Chronic Diseases, 1978; 7: 347-358.
16. Froberg, D. G. and Kane, R. L. Methodology for measuring health sate preferences - III: population and health effects. Journal of Clinical Epidemiology, 1989; 42: 585-592.
17. Council of Europe Press. Recent demographic developments in Europe, 1993. Strasbourg: Council of Europe Press, 1994.
18. Welch, H. G. Comparing apples and oranges: does cost-effectiveness analysis deal fairly with the old and young. The Gerontologist, 1991; 31: 332-336.
19. Schneider, E. L. Options to control the rising health care costs of older Americans Journal of the American Medical Association, 1989; 261: 907-908.
20. Schneider, E. L. and Guralnik, J. M. The ageing of America: impact on health care costs. Journal of the American Medical Association, 1990; 263: 2335-2340.
21. SIG (Stichting Informatiecentrum voor de Gezondheidszorg), on request.
22. Kawachi, I. and Malcolm, L. A. The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. Journal of Hypertension, 1991; 9: 199-208.
23. Katz, D. A. and Cronenwett, J. L. The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms. Journal of Vascular Surgery, 1994; 19: 980-991.
24. Russell, J. G. B. Is screening for abdominal aortic aneurism worthwhile? Clinical Radiology, 1990; 41: 182-184.
25. Hogenhuis, W., Stevens, S. K., Wang, P., Wong, J. B., Manolis, A. S., Mark Estes, N.A. and Pauker, S.G. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation, 1993; 88 (part 2): 437-446.
26. Desch, C. E., Hillner, B. E., Smith, T. J. and Retchin, S. M. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life expectancy outcomes. Journal of Clinical Oncology, 1993; 11: 777-782.
27. Schechter, C. B., Rose, D. N., Fahs, M. C. and Silver, A. L. Tuberculin screening: cost-effectiveness analysis of various testing schedules. American Journal of Preventive Medicine, 1990; 6: 167-175.
28. Leidl, R. Some factors to consider when using the results of economic evaluation studies at the population level. International Journal of Technology Assessment, 1994; 10: 467-478.
29. RIVM (Rijksinstituut voor Volksgezondheid en Milieuhygiene). Volksgezondheid toekomst verkenning; de gezondheidstoestand van de Nederlandse bevolking in de periode 1950-2010, pp. 75-102. The Hague: Sdu Uitgeverij Plantijnstraat, 1993.
30. Spilker, B. Guide to clinical trials. New York: Raven Press, 1991.
31. Baltussen, R. M. P. M., Ament, A. and Leidl, R. Making cost assessments based on RCTs more useful to decision-makers. Forthcoming in Health Policy, 1996; 37.
32. Eurostat. Demographic statistics 1994. Population and social conditions Series 3A. Brussels: Eurostat, 1994.
33. Bengtsson, H., Bergqvist, D. and Sternby, N. H., Increasing prevalence of abdominal aortic aneurisms; a necropsy study. European Journal of Surgery, 1992; 158: 19-23.
34. Statistics Bureau, Management and Coordination Agency. Japan statistical yearbook 1993/94. Tokyo: Japan Statistical Association, 1994.
35. Bureau of Statistics, Treasury Department. Statistical abstracts of the United States 1993, 113th edn. Washington, DC: Government Printing Office, 1994.
36. Verschuren, W. M. M., Smit, H. A., van Leer, E. M., Berns, M. P. H., Blokstra, A., Steenbrink-van Woerden, J. A. and Seidell, J. C. Prevalentie van risicofactoren voor hart- en vaatziekten en veranderingen daarin in de periode 1987-1991: eindrapportage Peilstationproject Hart- en Vaatziekten 1987-1991. Rapportnummer 528901011. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieuhygiene (RIVM), 1994 (in Dutch).
37. Canadian Coordinating Office for Health Technology Assessment. Guidelines for economic evaluation of pharmaceuticals: Canada. Ottawa: CCOHTA, 1994.
38. Goldman, L., Weinstein, M. C., Goldman, P. A. and Williams, L. W. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. Journal of the American Medical Association, 1991; 265: 1145-1151
39. Carr-Hill, R. A. Allocating resources to health care: is the QALY a technical solution to a political problem? International Journal of Health Services, 1991; 21: 351-363.
40. Harris, J. QALYfying the value of life. Journal of Medical Ethics, 1987; 13: 117-123.